Treatment of childhood and adolescent obesity

Endocrinologist

Volumn 14, Issue 3, 2004, Pages 138-143

  McDuffie, Jennifer R ^a,c   Yanovski, Jack A ^a,b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b U S PUBLIC HEALTH SERVICE   (United States)

^c IL   (United States)

Author keywords

Adolescence; And treatment; Childhood; Obesity; Weight loss

Indexed keywords

CAFFEINE; EPHEDRINE; MAZINDOL; METFORMIN; OCTREOTIDE; PHENTERMINE; RECOMBINANT LEPTIN; SIBUTRAMINE; TETRAHYDROLIPSTATIN;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ADOLESCENT; ANXIETY; BARIATRIC SURGERY; BEHAVIOR THERAPY; BODY MASS; CHILD; CHILD CARE; CHILDHOOD DISEASE; CLINICAL TRIAL; CONSTIPATION; DEFECATION DISORDER; DEPRESSION; DIAPHORESIS; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DRUG EFFECT; DRUG EFFICACY; EPIDEMIC; FLATULENCE; GALLSTONE; GROWTH HORMONE SUPPRESSION; HEART ARRHYTHMIA; HEART DISEASE; HEART PALPITATION; HORMONE INHIBITION; HUMAN; HYPERTENSION; HYPOTHYROIDISM; INSOMNIA; MYDRIASIS; NAUSEA; OBESITY; OILY FECES; PARESTHESIA; PATIENT REFERRAL; PHYSICAL ACTIVITY; POSTOPERATIVE COMPLICATION; PROTEIN DIET; PUBLICATION; RESTLESSNESS; REVIEW; SIDE EFFECT; SOFT STOOL; SOMNOLENCE; STEATORRHEA; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT PLANNING; TREMOR; XEROSTOMIA;

EID: 2542475164     PISSN: 10512144     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ten.0000127925.63097.f7     Document Type: Review

References (27)

1. Flegal KM, Carroll MD, Kuczmarski RJ, et al. Overweight an obesity in the United States: prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord. 1998;22:39-47.
2. Barlow S, Dietz W. Obesity evaluation and treatment: expert committee recommendations. Pediatrics. 1998;102:29-38.
3. Epstein L, Valoski A, Kalarchaian M, et al. Do children lose and maintain weight easier than adults: as comparison of child and parent weight: changes from six months to ten years. Obes Res. 1995;3:411-417.
4. Epstein L, Myers M, Raynr H, et al. Treatment of pediatric obesity. Pediatrics. 1998;101:554-570.
5. Steinbeck K. Conventional treatment for obesity. In: Chen C, Dietz W, eds. Obesity in Childhood and Adolescence, vol 49. Philadelphia: Lippincott Williams & Wilkins; 2002:207-222.
6. Epstein L, Valoski A, Wing R, et al. Ten-year outcomes of behavioral family-based treatment for childhood obesity. Health Psychol. 1994;13:373-383.
7. Epstein L, Goldfield G. Physical activity in the treatment of childhood overweight and obesity: current evidence and research issues. Med Sci Sports Exerc. 1999;31:553-559.
8. Sothern M, Loftin M, Udall J. Safety, feasibility, and efficacy of a resistance training program in preadolescent obese children. Am J Med Sci. 2000;319:370-375.
9. Sallis J, Prochaska J, Taylor W. A review of correlates of physical activity of children and adolescents. Med Sci Sports Exerc. 2000;32:963-975.
10. Braet C, Van Winckel M. Long-term follow-up of a cognitive behavioral treatment program for obese children. Behav Ther. 2000;31:55.
11. Yanovski J. Intensive therapies for pediatric obesity. In: Styne D, ed. Childhood and Adolescent Obesity, vol 48. Philadelphia: WB Saunders; 2001:1041-1054.
12. Suskind RM, Sothern MS, Farris RP, et al. Recent advances in the treatment of childhood obesity. Ann N Y Acad Sci. 1993;699:181-199.
13. Sothern M, von Almen T, Schumacher H, et al. A multidisciplinary approach to the treatment of childhood obesity. Del Med J. 1999;71:255-261.
14. Berkowitz R, Wadden T, Tershakovec A, et al. Behavior therapy and sibutramine for the treatment of adolescent obesity: a randomized controlled trial. JAMA. 2003;289:1805-1812.
15. McDuffie J, Calis K, Uwaifo G, et al. Three-month tolerability of orlistat in adolescents with obesity-related co-morbid conditions. Obes Res. 2002;10:642-650.
16. McDuffie J, Calis K, Booth S, et al. Effects of Orlistat on fat-soluble vitamins in obese adolescents. Pharmacotherapy. 2002;22:814-822.
17. Anonymous. Orlistat package inset. Nutley, NJ: Roche Pharmaceuticals; 2003:1-17.
18. Molnar D, Torok K, Erhardt E, et al. Safety and efficacy of treatment with an ephedrine/caffeine mixture. The first double-blind placebo-controlled pilot study in adolescents. Int J Obes Relat Metab Disord. 2000;24:1573-1578.
19. Farooqi S, Matarese G, Lord G, et al. Beneficial effects of leptin on obesity, T-cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest. 2002;110:1093-1103.
20. Lustig R, Rose S, Burghen G. Hypothalamic obesity caused by cranial insult in children: altered glucose and insulin dynamics and reversal by a somatostatin agonist. J Pediatr. 1999;135:162-168.
21. Kay JP, Alemzadeh R, Langley G, et al. Beneficial effects of metformin in normoglycemic morbidly obese adolescents. Metabolism. 2001;50:1457-1461.
22. Freemark M, Bursey D. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes. Pediatrics. 2001;107:E55.
23. Cummings D, Weigle D, Frayo R, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med. 2002;346:1623-1630.
24. Brolin R, Kenler H, German R, et al. The dilemma of outcome assessment after ope4rations for morbid obesity. Surgery. 1989;105:337-346.
25. Anderson A, Soper R, Scott D. Gastric bypass for morbid obesity in children and adolescents. J Pediatr Surg. 1980;15:876-881.
26. Rand C, MacGregor A. Adolescents having obesity surgery: a 6-year follow-up. South Med J. 1994;87:1208-1213.
27. Strauss R, Bradley L, Brlin R. Gastric bypass surgery in adolescents with morbid obesity. J Pediatr. 2001;138:499-504.